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Misassembly of full-length Disrupted-in-Schizophrenia 1
protein is linked to altered dopamine homeostasis and
behavioral deﬁcits
SV Trossbach1,13, V Bader1,13, L Hecher1, ME Pum2, ST Masoud3, I Prikulis1, S Schäble2,14, MA de Souza Silva2, P Su4, B Boulat5,
C Chwiesko5, G Poschmann6, K Stühler6, KM Lohr7, KA Stout7, A Oskamp8, SF Godsave9, A Müller-Schiffmann1, T Bilzer1, H Steiner10,
PJ Peters9,15, A Bauer8, M Sauvage5, AJ Ramsey3, GW Miller7, F Liu4, P Seeman11, NJ Brandon12, JP Huston2 and C Korth1
Disrupted-in-schizophrenia 1 (DISC1) is a mental illness gene ﬁrst identiﬁed in a Scottish pedigree. So far, DISC1-dependent
phenotypes in animal models have been conﬁned to expressing mutant DISC1. Here we investigated how pathology of full-length
DISC1 protein could be a major mechanism in sporadic mental illness. We demonstrate that a novel transgenic rat model, modestly
overexpressing the full-length DISC1 transgene, showed phenotypes consistent with a signiﬁcant role of DISC1 misassembly in
mental illness. The tgDISC1 rat displayed mainly perinuclear DISC1 aggregates in neurons. Furthermore, the tgDISC1 rat showed a
robust signature of behavioral phenotypes that includes amphetamine supersensitivity, hyperexploratory behavior and rotarod
deﬁcits, all pointing to changes in dopamine (DA) neurotransmission. To understand the etiology of the behavioral deﬁcits, we
undertook a series of molecular studies in the dorsal striatum of tgDISC1 rats. We observed an 80% increase in high-afﬁnity DA D2
receptors, an increased translocation of the dopamine transporter to the plasma membrane and a corresponding increase in DA
inﬂow as observed by cyclic voltammetry. A reciprocal relationship between DISC1 protein assembly and DA homeostasis was
corroborated by in vitro studies. Elevated cytosolic dopamine caused an increase in DISC1 multimerization, insolubility and
complexing with the dopamine transporter, suggesting a physiological mechanism linking DISC1 assembly and dopamine
homeostasis. DISC1 protein pathology and its interaction with dopamine homeostasis is a novel cellular mechanism that is relevant
for behavioral control and may have a role in mental illness.
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INTRODUCTION
Disrupted-in-schizophrenia 1 (DISC1) is a gene involved in
vulnerability to behavioral disorders. It was discovered in a large
Scottish pedigree with a chromosomal translocation leading to a
3′ truncation of the DISC1 gene and, putatively, a C-terminal
truncation of the resulting protein.1 In this family, the transloca-
tion is associated with several major clinical diagnoses such as
schizophrenia, recurrent major depression and bipolar disorder.1–3
Subsequent genetic association studies in multiple populations of
different ethnicities support the involvement of DISC1 in mental
illnesses (reviewed in refs. 4,5). For example, the coding
polymorphisms S704C (rs821616) and L607F (rs6675281) in DISC1
were associated with mental illness and also showed increased
DISC1 protein aggregation in vitro.6,7 In parallel, various transgenic
or genetically altered mouse models have been developed, either
targeting the mouse Disc1 locus or introducing mutant human
DISC1 variants. Missense mutations,8 deletion variants9,10 or partial
knockout of the endogenous mouse Disc1 locus11 were generated.
In addition, the dominant-negative truncated form of human
DISC1, which is thought to correspond to the truncated DISC1
gene in the Scottish family, was also induced12 or constitutively13
expressed in mouse models. Together these studies have
provided evidence of DISC1 being involved in neurodevelopment
and behavioral control.14
Thus far, DISC1 mouse models have been used to investigate
the role of genetically altered or silenced DISC1 in behavioral
control rather than the full-length form present in all sporadic
cases of chronic mental illness that may, at least in part, underlie
the etiology of the disorder.
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The fact that DISC1 has not yet been identiﬁed among the
major GWAS hits has raised controversies15,16 even though it
merely indicates that DISC1 is not targeted by common risk
variants. It has been pointed out that the study of rare gene
variants may provide valuable insights into disease mechanism.
One such example is Alzheimer's disease (AD) where common
mutations in the major disease genes APP and the presenilins also
do not appear in GWAS screens17 even though APP processing is a
critical step in AD pathogenesis.
Genetic association, however, is only one way to address the
connection between a disease and its biological cause. Investiga-
tions of the protein itself can also validate its role in non-familial
forms of a brain disease. For example, protein pathology is a major
biological cause for most chronic brain diseases such as AD,
frontotemporal dementias or Parkinson's disease in which a
dysfunctional proteostatic system leads to the accumulation of
disease-speciﬁc protein aggregates.18 Remarkably, in these
diseases the same proteins accumulate in sporadic forms as well
as familial genetic forms where these proteins are mutated.18
Furthermore, accumulation of proteins is a controlled process in
the cell that is even used to generate functional aggregates in
physiological circuitry.19
In this study, we asked whether non-mutant, full-length DISC1
could have a role in sporadic chronic mental illness including
schizophrenia and recurrent affective disorders. Speciﬁcally, we
investigated whether protein pathology or misassembly of DISC1
could have a role in causing mental illness. Our initial investiga-
tions using biochemical techniques identiﬁed insoluble DISC1 in a
subset of mental illness patients,20 leading to both gain and loss of
function interactions.20,21
Although both cellular and animal studies linked DISC1 to
various neurotransmitter systems,22 including the dopaminergic
system,23–28 the actual role of DISC1 in altering dopamine
signaling was not elucidated to molecular detail. Of note, in the
rodent and human brains, formation of a functional complex
between DISC1 and postsynaptic dopamine 2 receptors (D2R) has
been demonstrated.29
Here to mimic DISC1 protein misassembly, non-mutant
full-length human DISC1 was modestly overexpressed as a
transgene in Sprague Dawley rats (tgDISC1 rats). Extensive
neurochemical, biochemical and behavioral analyses demonstrate
a signature of behavioral phenotypes including amphetamine
supersensitivity, hyperexploratory behavior and rotarod deﬁcits.
These phenotypes are attributable to: (1) a switch of low afﬁnity to
high afﬁnity dopamine D2 receptors and (2) increased clearance of
extracellular dopamine due to translocation of the dopamine
transporter (DAT) in the dorsal striatum (dStr) of tgDISC1 rats. A
reciprocal relationship between DISC1 aggregation and dopamine
homeostasis suggests that DISC1 may act as a sensor of cytosolic
oxidative stress. Regulation of DISC1 assembly through environ-
mental insults may therefore impact dopamine homeostasis.
MATERIALS AND METHODS
Generation of the DISC1 transgenic rat
Transgenic Sprague Dawley rats were generated by injecting the linearized
fragment of the CosSHa.tet vector30 containing the full-length, non-mutant
human DISC1 as transgene with the polymorphisms F607 and C704 into
pronuclei of Sprague Dawley rats (contracted to the IBZ University of
Heidelberg, Germany). Integration of the transgene in the genome of the
resulting litters was conﬁrmed in independent founder animals by PCR and
Southern blotting of genomic DNA extracted from tail biopsies.
Subsequent breeding with wild type Sprague Dawley rats excluded
transgenic founders that did not carry the transgene in their germline. By
quantitative RT-PCR of genomic DNA and western blotting of brain
homogenate the transgene load as well as expression level was compared
between the four resulting stable founder lines.
Transgene detection by PCR and qPCR
Genomic DNA was prepared by digesting tail biopsies in 100mM Tris pH 8,
5 mM EDTA, 0.2% SDS, 200mM NaCl and 100 μgml− 1 Proteinase K,
precipitation with isopropanol and solubilization in pure water.
PCR for the detection of the transgene was performed on the genomic
DNA by utilizing the HotStarTaq (Qiagen, Hilden, Germany) and primers
binding the transgene promoter region: forward 5′-CTGATCTCCAGAAGC
CCAAA-3′, reverse 5′-CAGGCCTATTCCTTGACAGC-3′. For the quantitative
real-time PCR the same primers for the transgene were used. For normali-
zation primers targeting the genomic sequence of the housekeeping gene
rat beta-actin were designed: forward 5′-GCAACGCGCAGCCACTGTCG-3′,
reverse 5′-CCACGCTCCACCCCTCTAC-3′. Real-Time PCR was conducted
with the StepOnePlus Real-Time PCR System (Applied Biosystems,
Carlsbad, CA, USA) and the Platinum SYBR Green qPCR SuperMix-UDG
(Invitrogen, Carlsbad, CA, USA). PCR conditions: 10 min at 95 °C, then 40
cycles of 15 s at 95 °C and 60 °C for 1 min. The data were processed with
the corresponding StepOne Software v2.3 (Thermo Fisher Scientiﬁc,
Waltham, MA, USA) and DISC1 expression was normalized to expression
level of beta-actin.
Animals and behavioral analyses
All experiments were conducted in conformity with the Animal Protection
Law approved by local authorities (LANUV NRW, Recklinghausen,
Germany). Male tgDISC1 rats (transgenic rat; TG), negative controls (NC)
and Wistar rats were bred in the Animal Facility at the University of
Düsseldorf, Germany. NCs were bred from constantly renewed transgene-
negative offspring. Male homozygous tgDISC1 rats of founder line 3, but
also line 1, non-transgenic littermates and NCs were used for the
experiments presented. Experiments were mainly performed in founder
line 3, but main results were validated in founder line 1. Rats were housed
three animals per cage under standard laboratory conditions, with light on
from 0700 to 1900 hours with food and water provided ad libitum.
Behavioral testing started at an age of 3–4 months. Animals were tested in
a randomized manner, alternating tgDISC1 rats and NCs, without blinding.
If not stated otherwise, then the behavioral experiments were
conducted in a separate sound-attenuated room and experiments were
performed under dim light. Behavior was recorded using an Eyseo Ecoline
Standard TV7002 camera (ABUS, Wetter, Germany) and analyzed with the
EthoVision software (EthoVision 3.1; Noldus, Wageningen, The Nether-
lands). After each trial in each experiment arena and objects were cleaned
with 70% ethanol. An n= 12 was used for all behavioral analyses if not
otherwise stated.
A routine pathology survey using conventional methods, for example,
hematoxilin–eosin and cresyl violet staining, did not show any aberrant
changes in organs of the central nervous system (brain, myelon),
peripheral nervous system (nervus ischiadicus), endocrinum (pituitary
gland, thyroid glands and adrenal glands), as well as in peripheral organs
(lung, liver, kidney, spleen, pancreas, gut, heart muscle and lymph nodes)
upon a routine exam (data not shown).
Novelty preference tasks. The tasks were carried out in an open-ﬁeld arena
(60× 60 × 30 cm, l ×w×h) with cues for orientation. Object exploration was
recorded manually, the criterion for exploration being active examination
of the presented objects. Two 1.5-l plastic water bottles, one ﬁlled with clear
water, the other one with purple-colored solution, were used as objects. The
day before the novelty preference tests animals were allowed to habituate
to the arena for 10min without presentation of objects. Tests were
separated by one week to minimize memory interference between the
tasks. Animals that did not explore an object in either sample or test trial
were excluded from the analysis (object recognition (OR): NC n=2 animals
excluded; object place recognition (OPR): NC n=4 animals excluded).
Object recognition. Animals were allowed to explore the arena with two
identical objects for a 5-min sample trial, followed by a second 5-min test
trial separated by a 25-min intertrial interval. In the test phase one object
was replaced by a new one, keeping the original positions. OR is deﬁned as
increased exploration of the novel in contrast to the old object.
Object place recognition. This test consists of a 5-min sample trial with
two similar objects, a 25-min intertrial interval and a 5-min test trial. In the
test trial animals are presented with one object at the same position as in
the sample trial (stationary object) and one displaced object that has been
moved to a new location. OPR is deﬁned as increased exploration of the
displaced compared with the stationary object.
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Rotarod. For the testing of motor learning, animals were trained to walk
on the rotating cylinder of a rotarod apparatus (Accelerating Rota-Rod,
Jones & Roberts, for rats 7750, Ugo Basile, Gemonio, Italy). Three trials with
a constant pace of 1 r.p.m. separated by a 50-min intertrial interval were
performed. In the ﬁrst trial each animal had 120 s to learn the task and was
supported by the experimenter to keep balance until it learned to walk on
the wheel for 3 s on its own. In the following trials animals were left alone
once they kept balance. Animals that failed to learn to walk on the wheel
in the following trials were excluded from the analysis (NC n= 2, TG n= 1).
The trial was ended when the animal fell off the rotarod. The latency to fall
in seconds was measured manually.
Low-dose amphetamine challenge. Testing was carried out in the TruScan
open-ﬁelds (Coulbourn Instruments, Whitehall, PA, USA), located in sound-
and light-isolated chambers (110× 70× 70 cm) on two consecutive days for
15min each. On the ﬁrst day the rats were tested following an injection
of saline (1 ml kg− 1; intraperitonial (i.p.)), on the second day their
behavior was recorded following the administration of d-amphetamine
(0.5 mg kg− 1; i.p.; in saline with an injection volume of 1ml kg− 1;
Sigma-Aldrich, St. Louis, MO, USA). Locomotion was automatically
measured by the TruScan light beam system.
Generation of mice with increased DAT and decreased VMAT2
expression
DAT overexpressing (DAT-OE) mice were generated using BAC transgen-
esis as previously described.31,32 In addition, mice with decreased
VMAT2 expression (VMAT2-DE) were generated by gene targeting as
outlined elsewhere.33,34 DAT-OE and VMAT2-DE mice were inter-crossed to
produce double-transgenic mice (DAT-OE:VMAT2-DE) that simultaneously
display high DAT expression and low VMAT2 expression (Masoud
and Ramsey, unpublished). DAT-OE:VMAT2-DE mice were used to
model accumulation of cytosolic dopamine due to increased dopamine
uptake coupled with reduced vesicular storage. All mice have a C57BL/6
background.
Synaptic plasma membrane preparation and DAT levels
Synaptic plasma membrane fractions of the striatum were prepared as
previously described.35,36 Striata were removed from the fresh rat brains,
frozen in 2-methylbutane on dry ice and stored at − 80 °C until used.
Measurement of D2High
The method for measuring the dopamine D2High receptors in rat striata
in vitro was performed as reported earlier.37,38 Striata were removed from
the fresh rat brains and stored at − 80 °C until usage. The dopamine
receptors in the rat striatal tissue were measured with [3H]domperidone
(2 nM ﬁnal concentration; custom synthesized as [phenyl-3H (N)]domper-
idone; 41.4 Ci per mmol; made by Moravek Biochemicals and Radio-
chemicals, Brea, CA, USA).
Dopamine D2High receptors were best deﬁned by the number of D2
receptors occupied by 100 nM dopamine, as compared with 1 nM
dopamine (where dopamine does not occupy any signiﬁcant amount of
D2 receptors; see ref. 38). Therefore, D2High was measured by the amount
of [3H]domperidone bound at 1 nM dopamine minus the amount bound at
100 nM dopamine (Y). The speciﬁc binding, S, of [3H]domperidone at 2 nM
was measured by the amount of [3H]domperidone bound at 1 nM
dopamine minus the amount bound in the presence of 10 μM S-(-)
sulpiride. The percent of D2 receptors in the high-afﬁnity state was deﬁned
by (Y/S) × 100%.
Cyclic voltammetry
Rats were sacriﬁced by rapid decapitation. The head was immediately
submerged into oxygenated ice-cold sucrose buffer. Following removal of
the brain, coronal slices (350 μm) from NC and TG animals were sectioned
with a vibratome and incubated at 32 °C in artiﬁcial cerebrospinal ﬂuid
(aCSF). DA release was electrically stimulated (1 pulse, 350 μA) using a
double-pronged stainless steel stimulating electrode placed into the
region of interest. DA release was recorded using a carbon ﬁber
microelectrode, placed in the slice to form an equilateral triangle with
the stimulating electrode. A cyclic voltage ramp (−0.4 V to 1.0 V to − 0.4 V)
was applied to the carbon ﬁber microelectrode and the resultant
background-subtracted current was measured. Application of waveform,
stimulus and current monitoring was controlled by TarHeel CV (University
of North Carolina), using a custom potentiostat (UEI, UNC Electronics Shop).
A 5-stimulation recording survey of four different dorsal striatal and
nucleus accumbens sites were taken for each animal with a 5-min rest
interval between each synaptic stimulation. Following the experiment, the
carbon ﬁber microelectrode was calibrated using a ﬂow-cell injection
system and known dopamine standards. Kinetic constants were extracted
using nonlinear regression analysis of release and uptake of dopamine
from the extracellular space.
Receptor autoradiography
Animals were decapitated and their brains rapidly removed and
immediately frozen in 2-methylbutane (−50 °C) and stored until sectioning.
Coronal sections (20 μm) were produced in a cryostat microtome (Leica,
Nussloch, Germany), thaw-mounted onto silica-coated object slides and
stored at − 80 °C until further use.
Dopamine D2 receptors were labeled accordingly with [3H]raclopride
(0.56 nM) in 50mM Tris-HCl (pH 7.4; 45 min at 22 °C) containing 0.1%
ascorbic acid and NaCl (150mM), using the displacer butaclamol (1 μM).
Slices exposed to phosphor-imaging plates for 3 days together with
tritium standards. Autoradiograms from phosphor-imaging plates were
scanned with a high-performance plate reader and subsequently
processed in a blinded manner using image-analysis software (AIDA
4.13; all Raytest, Straubenhardt, Germany).
Neurochemical analysis of post-mortem brain tissue
After dissection brain tissues were homogenized with an ultrasonic device
in 0.05 M perchloric acid (Janssen, Geel, Belgium) containing deoxyepine-
phrinehydrochlorid (Sigma-Aldrich) as the internal standard. Dopamine
content was electrochemically detected as previously described39 and
analyzed with the Chrom Perfect Software (Justice Laboratory Software,
Denville, NJ, USA).
Rat and mouse insoluble proteome preparation
Transgenic and control mouse brain medial prefrontal cortex (mPFC) and
hemispheres of heterozygous TG and NC rats were isolated and weighed.
Each tissue piece was homogenized in 2.5% buffer A (50mM HEPES pH 7.5,
300mM NaCl, 250 mM sucrose, 5 mM GSH, 5 mM MgCl2, 1% NP-40, 0.2%
sarcosyl, 2 × protease inhibitor, 1 mM PMSF), supplemented with 40 Uml− 1
DNaseI and incubated for 30min at 37 °C followed by 16 h at 4 °C.
Next, samples were spun at 1800 × g for 30 min at 4 °C. The pellet was
resuspended in buffer B (50mM HEPES pH 7.5, 1.5 M NaCl, 250 mM sucrose,
5 mM EDTA, 5 mM GSH, 1% NP-40, 0.2% sarcosyl, 2 × protease inhibitor,
1 mM PMSF) and centrifuged at 1800× g for 30 min at 4 °C. The resulting
pellet was washed in buffer C (50mM Tris pH 8, 250mM sucrose, 5 mM GSH,
1% NP-40) and spun at 1800 × g for 30 min at 4 °C. The pellet was
resuspended in buffer D (50 mM HEPES pH 7.5, 5 mM GSH, 1% NP-40,
2 × protease inhibitor). Finally, the pellet was resuspended in buffer D´
(50mM HEPES pH 7.5, 0.2% sarcosyl, 2 × protease inhibitor) and spun at
100 000 x g for 45 min at 4 °C in an ultracentrifuge (TLA-55 rotor in Optima;
Beckman Coulter, Krefeld, Germany). The resulting insoluble pellets were
solubilized in 2 × SDS-loading buffer and used for western blots. Thus, we
deﬁne insoluble pellet as what is pelleting after centrifugation in cold ionic
detergent.
The preparation of the insoluble proteome of mPFC and dStr of
transgenic rats was performed as previously described.20 Transgenic DISC1
was detected with the huDISC1 speciﬁc mAb 14F2 and ﬂuorescent
secondary anti-mouse antibody (IRDye 800CW Goat anti-Mouse IgG,
LI-COR Biosciences, Lincoln, NE, USA).
Structural MRI analysis and calculation of ventricle size
Structural MRI imaging was performed on a 7.0 tesla small animal Scanner
(Bruker BioSpin, Billerica, MA, USA) with a horizontal bore magnet. The
system included a 20-cm Gradient and a 29-cm shimm system. For RF
transmission a transmit only quadrature coil (inner diameter 86mm)
(Bruker BioSpin) was used. RF reception was carried out with a rat brain 20-
mm surface loop coil (Bruker BioSpin). Forty-eight coronal slices
(0.156× 0.156× 0.5 mm) with a matrix of 256× 256, FOV 4 cm×4 cm, were
recorded using a RARE sequence: TE 14.370 ms, TR 7080 864ms,
4 averages, RARE factor of 4, scan duration of 15min 6 s. During image
recording animals were kept under 2% isoﬂurane. Respiration and body
temperature were monitored and controlled throughout the entire
Misassembly of full-length DISC1
SV Trossbach et al
1563
Molecular Psychiatry (2016), 1561 – 1572
experiment. For the analysis the Anatomist/ BrainVisa program version
4.3.0 (NeuroSpin, Gif-sur-Yvette, France) was used.
Immunohistochemistry of rat brains
For the immunostaining of transgenic rats animals were perfused with
phosphate-buffered saline (PBS) pH 7.4 and sagittal cryo sections were cut
on a Cryostat (Leica CM1900; Leica, Germany) and dried for 20min at RT.
The sections were post-ﬁxed with ice-cold 4% paraformaldehyde solution
buffered with PBS pH 7.4 (PFA, Sigma-Aldrich, MO, USA). After blocking
with antibody diluent (Dako, Hamburg, Germany) sections were incubated
with the mAb 3D4 for 16 h at 4 °C in antibody diluent. After two PBS
washes the secondary antibody (anti-mouse IgG AlexaFluor594 1:300;
Invitrogen) was applied for 1 h at RT. Sections were washed in PBS and in
PBS plus 0.05% Tween-20 for 10min. Subsequently sections were washed
shortly in distilled water, 70% ethanol and incubated 2 × 5min in Sudan
Black (Division Chroma, Münster, Germany) in 70% ethanol to block
autoﬂuorescence. After washing the sections in 70% ethanol and H2O, they
were mounted with ProLong Gold containing DAPI (Invitrogen). All images
were collected with a Zeiss Axiovision Apotome.2 confocal microscope
(Zeiss, Oberkochen, Germany).
Dopamine-induced DISC1 insolubility in cell culture
Human neuroblastoma SH-SY5Y cells were obtained mycoplasma-free
from the DSMZ (Leibniz Institute DSMZ-German Collection of Microorgan-
isms and Cell Cultures, Braunschweig, Germany) and tested at irregular
time intervals for mycoplasma contamination. SH-SY5Y cells expressing
inducible full-length human DISC1 were generated using the Retro-X
Tet-On Advanced Inducible Expression System (Clontech Laboratories,
Mountain View, CA, USA). SH-SY5Y cells were seeded onto glass coverslips,
induced for 24 h, treated with 100 μM DA for 24 h and ﬁxed with 4% PFA in
PBS. Cells were permeabilized with PBS (plus 0.5% saponine, 5% milk
powder, 1% BSA) and incubated with the mAb 14F2 and/or a vimentin
antibody (1:100; Cell Signaling, Danvers, MA, USA) and subsequent
AlexaFluor594 secondary antibody (Invitrogen) for 1 h in PBS plus 0.5%
saponine and 1% BSA was used. Cells were mounted with ProLong Gold
with DAPI (Invitrogen). Images were collected with a Zeiss Axiovision
Apotome.2 confocal microscope (Zeiss).
Puriﬁcation of the insoluble proteome of human neuroblastoma (NLF)
cells transfected with DISC1 and primary cortical neurons of the tgDISC1
rats were performed as described previously.6 Primary neurons at DIV 14
were incubated with 50 μM DA for 24 h to induce DISC1 aggregation and
then underwent the insoluble proteome puriﬁcation.
Cryoimmunogold electron microscopy
Cryoimmunogold electron microscopy was performed as described
previously.40
Co-immunoprecipitation of DISC1 by DAT in striatal membrane
preparations and cell lysates
For the co-immunoprecipitation (co-IP) of DAT and DISC1 striata of adult
tgDISC1 rats were dissected and the plasma membrane fraction was
puriﬁed by a sucrose gradient. The striatal tissue was homogenized in
buffer A (250mM sucrose, 50 mM HEPES pH 7.4, 15mM EDTA pH 8, 3 mM
DTT, protease inhibitor). After centrifugation at 500× g for 5 min at 4 °C
1ml of the supernatant was mixed with 1.7 ml of buffer D (2 M sucrose,
50mM HEPES pH 7.4, 15 mM EDTA pH 8, 3 mM DTT, protease inhibitor) to
gain a ﬁnal sucrose concentration of 1.34 M (now solution C). The sample
was layered on top of 1 ml of buffer D, followed by 1ml of buffer B
(850mM sucrose, 50 mM HEPES pH 7.4, 15 mM EDTA pH 8, 3 mM DTT,
protease inhibitor) and buffer A in 5ml ultracentrifugation tubes (Beckman
Coulter, Krefeld, Germany). The samples were centrifuged for 16 h at
100 000× g at 4 °C (MLS-50 rotor in Optima; Beckman Coulter, Germany).
Afterwards the interphase between layer B and C containing the membrane
fraction was collected, diluted with 3 volumes of PBS and frozen at − 80 °C
for 2 h for precipitation. After thawing and pelleting by centrifugation
(14 000×g at 4 °C for 30min), the membrane fractions were resuspended in
RIPA buffer (50mM Tris pH 7.6, 150mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS,
supplemented with 0.5mM DTT and protease inhibitor).
For the co-IP the solubilized membrane fractions (input: one rat striatal
hemisphere per IP reaction) were equally divided. One sample did not
receive an antibody for capturing, the other one was mixed with 3 μg
of a polyclonal antibody raised against DAT (AB2231, Merck Millipore,
Darmstadt, Germany) and incubated for 2 h at 4 °C, before addition of 20 μl
of Protein A/G magnetic beads (Pierce, Rockford, IL, USA) and further
incubation for 16 h at 4 °C. The beads were washed 4× with 1ml of 50mM
Tris pH 7.6, 150mM NaCl, 0.05% NP-40 and precipitated proteins were
eluted by addition of loading buffer containing 2% β-mercaptoethanol for
10min without boiling. Subsequently, the samples were used for western
blot and membranes were incubated with the 14F2 (detecting huDISC1)
and MAB369 antibody (detecting DAT; Merck Millipore).
Primary antibodies
For western blot: actin (rabbit, 1:10 000; Sigma-Aldrich); DAT (rat MAB369,
1:1 000; Merck Millipore); huDISC1 (mouse 14F2, 1:1 000; Korth lab21);
ratDISC1 (rabbit hu-precleared C-term,1:1 000; Korth Lab41); Na/K-ATPase
(rabbit, 1:1500; Cell Signaling; the antibody detects the α1 subunit. On the
basis of sequence homology, the antibody could also cross-react with α2
and α3 isoforms); Tubulin (mouse, 1:10 000, Sigma-Aldrich). For immunos-
taining: human DISC1 for ICC (mouse 14F2, 1:250; Korth lab); human DISC1
for IHC (mouse 3D4, 10 μgml− 1; Korth lab20); Vimentin for ICC (rabbit
D21H3, 1:100; Cell Signaling).
Western blot
For western Blots the Novex NuPAGE SDS-PAGE Gel System (all: Thermo
Fisher Scientiﬁc) with the corresponding NuPAGE Novex 4–12% Bis-Tris
Midi Protein Gels, NuPAGE MES SDS Running buffer and NuPAGE LDS
Sample Buffer (4 × , plus 8% β-mercaptoethanol) or Laemmli loading buffer
(4 × , 200mM Tris pH 6.8, 40% glycerol, 10% SDS, 0.4% bromphenolblue, 8%
beta-mercaptoethanol) was used. For molecular size estimation the
PageRuler Prestained Protein Ladder (#26617; Thermo Scientiﬁc, MA,
USA) was used. As the dyes used for prestaining of the marker proteins
inﬂuence their electrophoretic mobility, the apparent marker size was
calibrated to the PageRuler Unstained Protein Ladder (#26614; Thermo
Scientiﬁc) according to manufacturer’s instructions in the gel system used.
Accordingly, all depicted marker sizes have subsequently been adapted to
the calibrated sizes.
Densitometric analyses
Band intensities were calculated from luminescent sensitive ﬁlm
(Amersham Hyperﬁlm ECL; GE Healthcare, Buckinghamshire, UK) using
the ImageJ 10.2 software (National Institute of Health, Bethesda, MD, USA).
Alternatively ﬂuorescent secondary antibodies (LI-COR Biosciences, Lincoln,
NE, USA; 1:15 000 in PBS plus 0.05% Tween-20) were used and intensities
were analyzed on a LI-COR Odyssey CLX and the corresponding Image
Studio Version 2.1 software (LI-COR Biosciences).
Statistics
All statistical analyses were performed as indicated using the IBM SPSS
Statistic program (Versions 20–22; IBM, Ehningen, Germany) or GraphPad
Prism (Versions 4 and 5; GraphPad Software Inc., San Diego, CA, USA).
All data sets were tested for normal distribution based on the expected
experimental results and appropriate parametric or non-parametric tests
were chosen. An estimate of variation was made for selected analyses.
Comparison of two groups with similar variances was done by Student’s
t-test or Wilcoxon non-parametric test. Analyses were two-sided, if not
stated otherwise.
Sample size was chosen according to Fisher’s exact test and the
expected difference between experimental conditions. Animal behavior
was analyzed by two-way repeated measures analysis of variances
(ANOVAs) with the variables genotype and treatment, object, or trial, thus
considering correcting for multiple testing. Signiﬁcant effects of the
independent variables were explored further by splitting the data
appropriately and conduction of lower level ANOVAs and post hoc
comparisons including respective corrections for multiple testing. Paired
sample t-tests were applied when appropriate.
Appropriate statistical tests and P-values are stated in the respective
ﬁgure legends and/or results section. P-values of *P⩽ 0.05, **P⩽ 0.01,
***P⩽ 0.001 were used as signiﬁcance levels.
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RESULTS
Neuropathology of tgDISC1 rats
Previously, we reported the presence of insoluble DISC1 in
biochemically puriﬁed fractions from post mortem cases of the
Stanley Medical Research Institute Consortium Collection (SMRI
CC)42 diagnosed with mental illness.20,21 To model DISC1
aggregation in vivo, we generated a transgenic rat modestly
overexpressing non-mutant, full-length human DISC1 under
control of the Syrian hamster prion protein (PrP) promoter
(tgDISC1 rat). These rats showed about 11-fold higher transgenic
human DISC1 expression compared with endogenous rat Disc1
protein levels (Supplementary Figure S1a and c; protein expres-
sion rates were measured at P58). We chose to include common
variants C704 and F607 as they are frequent in the normal
population43 and have been demonstrated to increase the risk to
mental illness4 and, in biophysical studies, DISC1 misassembly.6,7
The PrP promoter was utilized for two reasons: ﬁrst, it provides
pan-cellular expression in the brain that has previously been
demonstrated for DISC144 and, second, it leads to sufﬁcient
expression levels for inducing misassembly as successfully
demonstrated in non-prion animal models of protein conforma-
tional disease.45,46 The PrP promoter is broadly active at
embryonic day E13.5 in the mouse brain47 and continues to be
expressed into adulthood, while the Disc1 gene has two
expression peaks at E13.5 and around postnatal day P35.48
Four different founder lines were generated (Figure 1a), and the
founder line with the lowest expression level was selected
(Founder line #3; Figure 1a and Supplementary Figure S2) in
order to avoid artifacts due to strong overexpression. The level of
overexpression was estimated to be 11-fold higher than
endogenous Disc1 protein (Supplementary Figure S1a, c), how-
ever, precise determination is impossible due to dozens of splice
forms of both endogenous rodent and human DISC1.49 The
chosen founder line exhibited neuronal, mainly perinuclear DISC1
aggregates throughout the brain and in primary neuron prepara-
tions that co-stained with the centrosome marker γ-tubulin
(Figure 1b, Supplementary Figure S3a, b). We deﬁne DISC1
aggregation or misassembly (a broader term) using the following
criteria: (1) insolubility in ionic detergents upon biochemical
fractionation;20 and (2) presence of (perinuclear) inclusion-like
structures that may represent cellular accumulation of insoluble
material, as observed in some protein conformational diseases
like, for example, Huntington's disease.
There was accentuated DISC1 aggregation in dopamine-rich
dorsal striatum (dStr; Figures 1b and c) that could not be
explained by differences in PrP promoter activity (Supplementary
Figure S2b), suggesting that posttranslational mechanisms
led to an enrichment of aggregated DISC1. Aggregation of
the transgenic DISC1 protein also led to recruitment of
endogenous rat Disc1 in the insoluble fraction (Supplementary
Figures S2c, d).
No major pathology was observed in peripheral organs or the
brain of tgDISC1 rats (data not shown). However, we did detect
slightly enlarged ventricles in the brain (Figure 1d), a trait also
observed in patients with schizophrenia50 and some transgenic
mouse models expressing mutant DISC1.10,12,13,26 Of note, the
mainly perinuclear DISC1 aggregates were not positive for ThS
(Supplementary Figure S4a and b), a marker for amyloid, even
though a recombinant DISC1 fragment (598–785 (ref. 6)) injected
into the brain of wild-type rats did stain for ThS (Supplementary
Figure S4c). This indicates that DISC1 or its fragments are
principally able to form amyloid, but not when endogenously
expressed in adult or aged tgDISC1 rats.
Dopamine-related behavioral phenotypes of tgDISC1 rats
Similar to patients with schizophrenia,51 tgDISC1 rats exhibited
spontaneous amphetamine supersensitivity. When challenged
with a single low-dose of 0.5 mg kg− 1 d-amphetamine
(Figures 2a and b), tgDISC1 rats exhibited increased locomotion
and rearing behavior, whereas negative control rats did not.
A two-way ANOVA revealed a main effect for treatment (distance:
F1,22 = 19.026, Po0.001; rearing: F1,22 = 43.909, Po0.001) and
genotype-treatment interaction (distance: F1,22 = 6.052, P= 0.022;
rearing: F1,22 = 17.706, Po0.001). A paired t-test of locomotion
data during saline and amphetamine for the two genotypes
revealed that tgDISC1 rats exhibited a large increase in locomo-
tion upon amphetamine treatment (distance and rearing:
Po0.001), whereas NCs did not respond (distance: P= 0.280;
rearing P= 0.146). Amphetamine supersensitivity was persistent
even in 22-month-old tgDISC1 animals (Supplementary Figures
S5a and b). This suggests that disturbance in the dopamine
system of tgDISC1 rats is a persistent, life-long trait.
Furthermore, tgDISC1 rats exhibited motor deﬁcits in the
rotarod task (Figure 2c). A two-way ANOVA checking for genotype
differences in the learning curve of the rotarod task showed a
main effect for genotype (F1,19 = 7.534, P= 0.013) and trial
(F2,38 = 3.360, P= 0.045). Subsequent post hoc unpaired t-tests
for trials 1, 2, 3 comparing genotypes revealed a signiﬁcant
difference in trial 3 performance (P= 0.041), whereas no
differences could be detected in the ﬁrst two trials (trial 1:
P= 0.217; trial 2: P= 0.122). These major behavioral phenotypes
were conﬁrmed in a different founder line as well (Supplementary
Figure S6).
Spatial and object memory was also tested in tgDISC1 rats using
novelty preference tasks. Although both genotypes could
distinguish objects in the OR, OPR and object recognition for
temporal order paradigms (Supplementary Figure S7), tgDISC1
rats displayed a marked preference towards novel objects
compared with controls (Figures 2d and e). This preference was
also persistent in old age (Supplementary Figures S5c and d).
In the OR task, rats have to identify the new object presented
in the test trial. A two-way ANOVA showed main effects for
object (F1,20 = 31.110, Po0.001) and object-genotype interaction
(F1,20 = 9.343, P= 0.006). A subsequent one-way ANOVA
revealed genotype differences in hyperexploration of the new,
but not the old object (old P= 0.737, new P= 0.048). However, in
general both genotypes preferred exploration of the new over the
old object (data split for genotype; paired t-test: NC P= 0.045, TG
Po0.001). Comparable behavioral results were detected in the
object place recognition task in which the animal has to
discriminate between the displaced and the stationary object.
Here, the two-way ANOVA showed main effects for both object
(F1,18 = 26.118, Po0.001) and genotype (F1,18 = 6.923, P= 0.017),
again highlighting hyperexploration of the more interesting
displaced object in tgDISC1 rats (one-way ANOVA stationary
P= 0.128, displaced P= 0.019). Comparisons of exploration time of
the stationary and displaced object by a paired t-test show
that both genotypes investigate the displaced object for longer
(NC P= 0.021, TG P= 0.001).
As amphetamine supersensitivity indicated a disturbance in the
dopaminergic system, we performed ex vivo neurochemistry and
analysis of dopamine receptor densities in the striatum of
tgDISC1 rats. Dopamine concentrations were decreased in the
dStr (Figure 3a), amygdala and hippocampus (Supplementary
Figures S8a and b) of tgDISC1 rats. However, no changes were
detected in total D2Rs (Figure 3b), D1 receptors (D1Rs),
serotonergic, or glutamatergic receptors (Supplementary Figure
S8c) as measured by receptor autoradiography. Surprisingly, when
we investigated the afﬁnity state of D2Rs, we found an ~ 80%
increase in high afﬁnity D2 (D2High) receptors in tgDISC1 rats
(Figure 3c). A switch from low-afﬁnity D2Low to D2High receptors
is a characteristic feature of schizophrenia.52,53 To investigate
whether the changes in D2R afﬁnity state affected signaling
in striatal medium spiny neurons (MSNs), we assessed substance
P and enkephalin expression as markers of neuronal activity
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in D1R- and D2R-expressing MSNs (Supplementary Figure S8d),
respectively. We did not ﬁnd signiﬁcant changes indicating
that altered dopamine transmission in the dStr was not strong
enough to induce changes in substance P or enkephalin
expression.
To further characterize the dopaminergic system, we performed
fast-scan cyclic voltammetry in striatal slices from tgDISC1 rats and
controls. Peak dopamine release was similar between genotypes
(Figure 3d) but, interestingly, extracellular dopamine clearance
was increased in the dStr of tgDISC1 rats (Figure 3e, see also
Supplementary Figure S8e), indicating elevated DAT function.
Therefore, using dissected striata, we further investigated the
cellular localization of DAT. In tgDISC1 rats, signiﬁcantly more DAT
was translocated to the plasma membrane, likely explaining the
observed increase in dopamine clearance (Figure 3f and
Supplementary Figure S8f).
Taken together, these ﬁndings indicate that dopamine home-
ostasis is changed in tgDISC1 rats, as evidenced by D2R afﬁnity
state and DAT function. Thus, misassembly of full-length human
DISC1 is sufﬁcient to cause changes in the dopaminergic system
consistent with some biochemical and behavioral symptoms seen
in schizophrenia or psychosis.
Molecular and cellular interactions between DISC1 protein
assembly and the dopamine system
To further investigate interactions between DISC1 assembly and
dopamine on the cellular and molecular level, we generated
full-length human DISC1-inducible SH-SY5Y cell lines (Figure 4a).
We did not detect different aggresomal sizes in the cell lines
expressing either the full-length human DISC1 (S704, L607) or the
(C704, F607) variant (Supplementary Figure S9). This suggests that
changes in misassembly of DISC1 polymorphisms observed in
biophysical studies do not translate to microscopically visible
differences. When these cells were induced to drive DISC1
expression and then exposed to a high, but non-toxic concentra-
tion of dopamine for 24 h, DISC1 aggresomes were detected
(Figures 4a and c; Supplementary Figure S10a). The DISC1
aggresomes were coated with vimentin, a deﬁning marker for
aggresomes54 (Figure 4c, Supplementary Figures S9a and b),
which also makes it unlikely that DISC1 is a component of the
aggresome machinery itself. Primary neurons and brain slices of
the tgDISC1 rat could not be stained to check for vimentin coating
of aggresomes, as vimentin is only expressed in proliferating
tissues.55 However, these cellular perinuclear DISC1 aggresomes
co-localized with γ-tubulin, but neither with HSP70, nor the
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Figure 1. Aggregated DISC1 detected by IHC in brains of the tgDISC1 rat. (a) Western blot comparing transgene expression and aggregation
in four different tgDISC1 founder lines. Heterozygous rats of founder lines 1, 3, 5 and 7 displayed different levels of full-length human DISC1
transgene expression (homogenate) which were reﬂected in the insoluble fraction. No huDISC1 could be detected in the negative control
animal. Beta-actin was used as loading control in the homogenate. Relative number of transgene copies in founder lines was determined by
quantitative Real-Time-PCR of genomic DNA and revealed the least transgene copies in the gDNA of founder 3 (arbitrarily set to one for
comparison between founder lines) and a Mendelian-like inheritance pattern upon breeding. Founder line 3 with the weakest DISC1
expression was chosen for further experiments to avoid artifacts of too strong transgene expression. (b) Confocal immunoﬂuorescence of
striatal (dStr, right panels) and frontal (left panels) cryosections of the transgenic DISC1 rat (middle and in higher magniﬁcation in lower
panels) and a negative control rat (upper panels). Abundant punctuate, mainly perinuclear staining as evidence for the existence of DISC1
aggregates can be detected that are more frequent and bigger in the striatum. Green: DISC1; blue: DAPI; bar 40 μm (upper two panels), bar
10 μm (lower panels). (c) Densitometric analysis of biochemically puriﬁed insoluble fraction of the tgDISC1 rat mPFC and dorsal striatum. The
tgDISC1 rat (n= 6) had more aggregated DISC1 in the dStr than in the mPFC in accordance with the IHC. Wilcoxon *P= 0.028. (d) NMR analysis
of ventricle size. The tgDISC1 rat (n= 8) had a larger total ventricle size than negative controls (n= 10), namely 20.75± 2.5 mm3 in tgDISC1 rats
and 15.54± 0.9 mm3 in negative controls. Unpaired t-test: P= 0.052. All means± s.e.m. DISC1, Disrupted-in-Schizophrenia 1; gDNA, genomic
DNA; NMR, nuclear magnetic resonance.
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oligomer-speciﬁc marker A11, or the amyloid marker ThT
(Supplementary Figure S10b and c).
This increase in DISC1 misassembly upon exposure to dopamine
is consistent with our observation of increased DISC1 aggregation
in the dStr (Figures 1b and c), which is the brain region with the
highest dopamine content (Supplementary Figure S8b).
These results suggest a bidirectional link between dopamine
homeostasis and DISC1 assembly because not only did DISC1
assembly regulate D2R afﬁnity state and DAT function in vivo, but
also because increased cytosolic dopamine itself augmented
DISC1 insolubility. To investigate whether DISC1 could interact in a
complex with DAT we performed co-immunoprecipitation experi-
ments. First, using plasma membrane fractions from the striatum
of tgDISC1 rats, we demonstrated that DAT antibody co-
immunoprecipitated transgenic human DISC1 (Figure 4d). Second,
using SH-SY5Y cells that overexpress DISC1 and DAT, we
demonstrated co-immunoprecipitation of DISC1 by DAT
(Supplementary Figure S11b), as well as subcellular colocalization
in vivo of the two proteins using immunoﬂuorescence and the
Proximity Ligation Assay56 (Supplementary Figures S12). Further-
more, dopamine-induced DISC1 aggregates (Figure 4a) were also
able to sequester DAT into the insoluble fraction (Supplementary
Figures S13c and d). Taken together, all these in vivo and in vitro
results converge on the demonstration of a functional complex
comprising DISC1 and DAT.
Pulse treatment of DISC1-transfected cell lines and primary
neurons of the tgDISC1 rat with a single, high and non-toxic dose
of dopamine induced a high-molecular-weight (HMW) band with
an electrophoretic mobility of ~ 200–230 kDa in western blots
suggesting a biochemical signature of dopamine-induced DISC1
multimers (Figure 5a and Supplementary Figure S14a). The
identity of this band as DISC1 was conﬁrmed by mass spectro-
metry (Supplementary Figure S14b and c). Dopamine-induced
appearance of this HMW band and aggresome-positive cells could
not be prevented by addition of D1R or D2R antagonists
(Supplementary Figure S15). However, it was partially inhibited
by a DAT inhibitor (Supplementary Figure S16) suggesting that
these phenotypes were not induced by signaling events but by
the presence of cytosolic dopamine.
To further investigate whether conditions that lead to increased
cytosolic DA in vivo can also induce the HMW DISC1 band, we
used transgenic mice that are postulated to have elevated levels
of cytosolic dopamine. In particular, we used mice that either
overexpress DAT (DAT-OE), underexpress VMAT2 with only ~ 5%
of normal levels (VMAT2-DE) or double-transgenic mice (DAT-OE:
VMAT2-DE). Using puriﬁed insoluble fractions from the mPFC of
these mice, we demonstrated an increase in the endogenous
HMW DISC1 band in DAT-OE and DAT-OE:VMAT2-DE brains
(Figure 5b), thus conﬁrming cytosolic dopamine-induced
aggregation of DISC1 in vivo. The identity of this HMW band
Figure 2. Behavioral phenotypes of the tgDISC1 rat. (a) Amphetamine hypersensitivity in the tgDISC1 rat shown by horizontal locomotion.
Spontaneous locomotion before (saline; white bars) and after (gray bars) application of a single low dose of d-amphetamine (0.5 mg kg− 1, i.p.)
is presented. Whereas the d-amphetamine had no signiﬁcant locomotor effect in the control animals (paired t-test: P= 0.280, n= 12), it led to
increased locomotion in the tgDISC1 rat indicating hypersensitivity to d-amphetamine (paired t-test ***Po0.001, n= 12). (b) Amphetamine
hypersensitivity in the tgDISC1 rat shown by duration of rearing. Only tgDISC1 rats reacted with increased duration of rearing to
d-amphetamine treatment (gray bars) compared with saline (white bars; paired t-test: negative controls (NC) P= 0.146, TG ***Po0.001; TG and
NC n= 12). (c) The rotarod task as measure of motor learning ability and attention. Under constant speed of the wheel, the negative control
animals showed a signiﬁcant progressive improvement in walking on the rotarod over three subsequent trials, whereas the transgenics did
not display such a learning curve (t-test of trial 3: *P= 0.041; TG n= 11, NC n= 10). (d) Hyperexploration of tgDISC1 rats in the object
recognition task (OR). Comparing duration of exploration of the new vs the old object in tgDISC1 rats and controls during OR test trial (TG
n= 12, NC: n= 10) showed that tgDISC1 rats explored the new object more extensively than the negative controls (one-way ANOVA:
#P= 0.048), although both genotypes preferred the new over the old one (paired t-test: NC *P= 0.045, TG ***Po0.001). (e) Hyperexploration of
the tgDISC1 rats in the object place recognition task (OPR). Comparably, in the OPR task (TG n= 12, NC n= 8) the tgDISC1 rats explored the
displaced object longer than control rats (one-way ANOVA: #P= 0.019). Again, both genotypes favored the displaced over the stationary
object (paired t-test; NC *P= 0.021, TG **P= 0.001). All means± s.e.m. DISC1, Disrupted-in-Schizophrenia 1; i.p., intraperitonial.
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under different conditions was determined for endogenous rat
and mouse Disc1 as well as artiﬁcially expressed human DISC1
(in tgDISC1 rats) using an overlay of species-speciﬁc antibody
signals (Figure 5c).
Amphetamine sensitization is a pharmacological model of
psychosis.57 Amphetamine is known to block and even reverse
DAT's ability to transport dopamine out of the presynapse,58
thereby enhancing extracellular dopamine concentrations. Sensi-
tization with amphetamine leads to the depletion of stored
dopamine in the striatum and enhancement of dopamine in the
typically low dopamine-containing mPFC.57 We sensitized wild-
type rats for 5 days with daily doses of 2 mg kg− 1 amphetamine,
and probed them after a 2-week interval with a single dose of
0.5 mg kg− 1 amphetamine for behavioral testing of supersensi-
tivity (Supplementary Figure S17a). Afterwards, animals received
another high dose of amphetamine and 24 h later the mPFC and
dStr were dissected and the insoluble proteome was puriﬁed and
probed for Disc1. Although we could not detect a difference in
Disc1 aggregation in the mPFC, we observed decreased insoluble
Disc1 in the dStr upon DA depletion (Supplementary Figure S17b
and d). According to these results, the presence of endogenous
insoluble Disc1 is correlated with cytosolic DA levels in wild
type rats.
DISCUSSION
We present the ﬁrst transgenic rat model for one of the best-
characterized genes implicated in mental illness, DISC1. We
demonstrate that modest overexpression of full-length human
DISC1 causes DISC1 misassembly and a signature of neuropatho-
logical, biochemical and behavioral phenotypes involving the
dopamine system.
DISC1 is a gene for which mutations or polymorphisms have
been associated with chronic mental illnesses like schizophrenia,
recurrent major depression, bipolar disorder and autism. This
highlights the role of DISC1 as a general vulnerability factor for
behavioral control that is not restricted to one speciﬁc mental
illness, despite its name.4,5,14 Here, we present a novel mechanism
by which full-length DISC1 protein without genetically linked
mutations may have a role in a subset of sporadic cases of chronic
mental illness, cases where a clear and unambiguous genetic basis
cannot be determined. Protein pathology, that is, misassembly of
Figure 3. Dorsal striatum and dopamine homeostasis in the tgDISC1 rat. (a) Neurochemical quantiﬁcation of post mortem dopamine (DA) in
the dStr of tgDISC1 and negative control animals. TgDISC1 rats (n= 12) had lower levels of DA as compared with negative controls (NCs)
(n= 12). TgDISC1 and negative control rats had 13 337± 375 and 11 675± 504 pg/mg DA. Unpaired t-test **P= 0.005. (b) Total D2 receptor
abundance in the dStr. Autoradiography was performed with the D2R speciﬁc radioligand [3H]raclopride. No difference in ligand binding and
therefore total receptor density could be found in tgDISC1 rats (n= 10) and controls (n= 10) in the dorsal striatum. Mean receptor density was
870± 26 fmol/mg protein for controls and 815± 26 for tgDISC1 rats. Unpaired t-test P= 0.156. (c) Elevated striatal D2High receptor portion in
tgDISC1 rats. TgDISC1 rats (n= 6) had an 81% increase in D2High receptor portions compared with negative controls (n= 6) as measured by
[3H]domperidone binding. Binding of the radioligand was challenged with either 1 nM or 100 nM DA, concentrations at which no signiﬁcant
occupation of D2Rs or D2High-speciﬁc binding occurs, respectively. Proportions of D2High receptors in relation to total D2 receptors were
33± 3.9% in NCs and 59.7± 6.5% in TGs. Unpaired t-test **P= 0.005. (d) Peak DA release in the dStr of tgDISC1 rats. Fast-scan cyclic
voltammetry measurement of DA in striatal slices revealed no difference in the peak release of DA in tgDISC1 rats (2.16± 0.43 μM; n= 4) and
controls (1.88± 0.58 μM; n= 6). Mann–Whitney U-test P= 0.762. (e) Clearance of extracellular DA in the dStr of tgDISC1 rats. TgDISC1 rats
(tau= 0.131± 0.006; n= 4) show increased extracellular DA clearance compared with negative controls (0.176± 0.006; n= 6) as measured by
fast-scan cyclic voltammetry. Mann–Whitney U-test *P= 0.036. (f) Striatal DAT levels in tgDISC1 rats. Preparation of the synaptic plasma
membrane (SPM) and subsequent western blotting revealed a 19% increase in dopamine transporter levels in the dorsal striatum of tgDISC1
rats (NC, TG n= 6). Densitometric analysis was performed by normalization of DAT to the Na/K-ATPase signal in the preparations. Unpaired
t-test **P= 0.004. All means± s.e.m.
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a gene product, is an established mechanism in chronic brain
diseases like Alzheimer's disease, Parkinson's disease and other
neurodegenerative disorders,18 as well as several non-brain
diseases.59 In addition, protein assembly to large, ordered
complexes occurs physiologically and plays important functional
roles, including synapse maintenance.19,60 DISC1 misassembly in
tgDISC1 rats led to a signature of biochemical and behavioral
phenotypes involving the dopamine system. These phenotypes
correspond to phenotypes that are also observed in schizophre-
nia, such as amphetamine sensitization and the switch from
low-afﬁnity to high-afﬁnity D2 receptors.52 Therefore, we present a
novel animal model with high face validity that is relevant for a
signiﬁcant subset of human cases with DISC1-dependent mental
illness, tentatively termed DISC1opathies.61
In the tgDISC1 rat, we chose to overexpress full-length DISC1
containing the C704 and F607 polymorphisms because they
increase aggregation propensity in cell-free in vitro systems.6,7
Both polymorphisms are common alleles that do not predict
mental illness as opposed to mutations. Therefore, when
evaluating the potential contribution of these polymorphisms on
the observed phenotypes, genetic and protein aggregation effects
cannot be separated because both phenomena are linked.
Furthermore, when expressed in cells, aggregation propensity of
the DISC1 protein seems to override effects of polymorphisms
(Supplementary Figure S9).
In addition to prominent amphetamine supersensitivity, the
hyperexploratory behavior and rotarod deﬁcits can also be related
to subtle alterations in the striatal dopaminergic system, which is
essential for motor control, reward-related behaviors and explora-
tion. The dStr acts as a convergence point for inputs from the
basal ganglia, cortex and thalamus. From the dStr, the direct and
indirect pathways arise and exert opposing control over motor
function. This is mediated by D1R- and D2R-expressing MSNs that,
respectively, promote or inhibit locomotion and exploration.62
Both pathways are thought to be partially intertwined63,64 and are
affected by dopaminergic input to the dStr. Increased striatal
dopamine reduces the excitability of D2R-MSNs and favors
locomotion and exploration by weakening the indirect
pathway.65,66 Our results indicate a subtle enhancement of
D2R-mediated neurotransmission in tgDISC1 rats: the large
(80%) increase in D2High receptors suggests ampliﬁcation of
D2R signaling that is probably not compensated by the modest
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Figure 4. Dopamine-induced DISC1 aggresome formation in cell models. (a) Confocal immunoﬂuorescence light microscopy of SH-SY5Y
human neuroblastoma cells induced for expression of full-length human DISC1 (S704, L607). DISC1 was diffusely expressed throughout the
cytoplasm (left panel). Upon DA treatment (100 μM for 24 h; right panel) the previously diffusely distributed DISC1 built up aggresomes inside
the cell. Bar 20 μm. (b) Cryoimmunogold electron microscopy for cells from a. Arrow marks the perinuclear, immunolabeled dopamine-
induced DISC1 aggresome. Bar 100 nm. (c) Characterization of dopamine-induced DISC1 aggresomes as shown in a. Double-staining shows
that DA-induced DISC1 aggresomes (red) are caged by vimentin (green). Bar 20 μm. (d) Co-immunoprecipitation of DISC1 by DAT in the
tgDISC1 rat brain. In a plasma membrane preparation of the striatum the DAT antibody co-immunoprecipitated transgenic human DISC1.
Upper two panels show DISC1 signal, lower two panels DAT signal at two different exposure times. DA, dopamine; DISC1, Disrupted-in-
Schizophrenia 1; M, mitochondrion.
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increase in dopamine clearance by DAT. Overall, this would lead to
increased D2R-MSN activation promoting hyperexploration in
tgDISC1 rats. This might also explain the rotarod deﬁcits in these
animals as motor learning is mediated by D2R-MSNs and can be
disrupted by exploratory distraction as shown by cell-type speciﬁc
striatal lesion studies.67 Mutations in the DISC1 gene have been
linked to aberrant dopamine-related functions. Amphetamine
supersensitivity was observed in mouse mutants and in transgenic
mice expressing C-terminal deleted DISC1 (1–597).23,24,26 Also in
these transgenic mice, changes were subtle as similar basal DA
levels were detected in the dStr.23,26 Although the Disc1 (L100P)
mutant mouse showed elevated D2High receptors in the dStr,23
the transgenic mouse expressing C-terminal deleted DISC1
showed more D2R and DAT in the dStr.24 DA-related behavioral
and biochemical phenotypes have consistently been found in
Disc1 mouse mutants and transgenic mice expressing mutant
DISC1 gene. Given that partial Disc1 knockout or localized Disc1
silencing25 as well as overexpression of non-mutant DISC1 (as
shown here) both lead to DA-related phenotypes, it appears that
DISC1 protein expression has to be tightly regulated within a
narrow range to maintain functional dopamine homeostasis. Thus,
DISC1 integrity as well as expression levels seem to have a critical
role in dopamine homeostasis.
Our demonstration of a reciprocal relationship between DISC1
misassembly and the major neuromodulator dopamine was
unexpected. Unlike other neurotransmitters, cytosolic dopamine
is a highly reactive oxidant68 and is able to induce or accentuate
oxidative damage. The suggested connection between DISC1
assembly, DAT function, and cytosolic dopamine could therefore
have an important role in controlling cellular stress. We postulate
that DISC1 assembly / misassembly could act as a molecular
sensor for cellular oxidative stress. Whether the observed DISC1
aggregates20,21 are archaic remnants of oxidative stress events
should be further explored.
In summary, our investigations reveal signiﬁcant functions of
DISC1 in two major regulators of dopamine homeostasis: D2R
afﬁnity and DAT activity. Modest DISC1 overexpression in the
tgDISC1 rat causes changes in DISC1 assembly that directly
impacts dopamine homeostasis in the absence of genetic
mutations. Thus, we have identiﬁed a novel mechanism of DISC1
pathology involving protein insolubility that was previously
underappreciated as a potential risk factor for mental illness.
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